Ameritas Investment Company’s Edwards Lifesciences EW Stock Holding History

Ameritas Investment Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$328K	Buy	2,895 +1,614	+126%	+$184K	0.02%	535
2021 Q2	$259K	Sell	1,281 -10,257	-89%	-$967K	0.01%	607
2021 Q1	$965K	Buy	+11,538	New	+$975K	0.08%	225
2020 Q2	–	Sell	-960	Closed	-$60K	–	695
2020 Q1	$60K	Buy	+960	New	+$69.2K	0.01%	638
2019 Q4	–	Sell	-36	Closed	-$3K	–	1028
2019 Q3	$3K	Buy	+36	New	+$2.53K	﹤0.01%	1372
2019 Q2	–	Sell	-1,125	Closed	-$72K	–	418
2019 Q1	$72K	Buy	+1,125	New	+$64.2K	0.01%	393

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameritas Investment Company's EW Position: Q3 2021 in Review

Ameritas Investment Company increased its Edwards Lifesciences (EW) stake by 126% in Q3 2021, buying an estimated $184K and bringing the position to 2,895 shares worth $328K. The position accounts for 0.02% of the portfolio, ranked #535.

Ameritas Investment Company first reported a position in EW in Q1 2019 and has held it in 6 quarters since. The position peaked at $965K in Q1 2021. 1,228 funds tracked by Wall St. Rank hold EW as of Q3 2021.

Ameritas Investment Company held 2,895 shares of Edwards Lifesciences worth $328K as of Q3 2021.
Ameritas Investment Company bought 1,614 Edwards Lifesciences shares in Q3 2021, an estimated $184K.
Edwards Lifesciences made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #535 holding.
Ameritas Investment Company first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 6 quarters since.
Ameritas Investment Company's Edwards Lifesciences position peaked at $965K in Q1 2021.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.